Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bioavailability of Cobimetinib Tablet vs Capsule in Healthy Subjects
NCT02136524Phase 1Completed
- Sponsor
- Genentech
- Start
- Apr 2014
- Primary completion
- May 2014
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, randomised, open-label trial of cobimetinib in melanoma (2 arms), sponsored by Genentech. Primary endpoints: Maximum observed concentration, Time to maximum concentration and 5 more. Started Apr 2014; status: completed.
02
Drugs
cobimetinib
03
Conditions
melanoma
Beyond the preview
Go deeper on NCT02136524.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02136524.